The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients

NCT04108260 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia

Interventions

DRUG: Albutrepenonacog Alfa 1 UNT [IDELVION]

Sponsor

National Taiwan University Hospital